Stemgent, Inc. — Form D
Stemgent, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-05-13. The offering totals $10.1M, of which $5.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-05-13
- Form: D
- Accession: 0001140361-10-020792
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10.1M
- Amount sold: $5.6M
- Remaining: $4.5M
- Minimum investment: $500K
- Investors: 6
- Date of first sale: 2010-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-141981
Issuer
- Name: Stemgent, Inc.
- CIK: 0001429173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-494-0398
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| IAN RATCLIFFE | Director | Cambridge, MA |
| IAN RATCLIFFE | Executive Officer | Cambridge, MA |
| IAN RATCLIFFE | Promoter | Cambridge, MA |
| Augustine Lawlor | Director | South San Francisco, CA |
| Harold Werner | Director | Trevose, PA |
| Ralph Christoffersen | Director | South San Francisco, CA |
| Ralph E Christoffersen | Director | Louisville, CO |
| Augustine R Lawlor | Director | Cambridge, MA |
| Stefan E Miltenyi | Director | Bergisch Gladbach, 2M |
| Stefan Miltenyi | Director | Bergisch Gladbach, 2M |
| Augustine E Lawlor | Director | Cambridge, MA |
| Stefan R Miltenyi | Director | Bergisch Gladbach, 2M |
| Ralph R Christoffersen | Director | Cleveland, OH |
| Ian E Ratcliffe | Director | Cambridge, MA |
| Ian E Ratcliffe | Executive Officer | Cambridge, MA |
| Harold R Werner | Director | Malvern, PA |
| Ralph E. Christoffersen | Director | San Diego, CA |
| Stefan E. Miltenyi | Director | Bergisch Gladbach, 2M |
| Augustine R. Lawlor | Director | Cambridge, MA |
| Harold R. Werner | Director | Cambridge, MA |
Other filings by this issuer (6)
More